cefaliv
achÉ laboratÓrios farmacÊuticos s.a - mesilato de di-hidroergotamina, cafeÍna, dipirona - analgesicos contra enxaqueca
enxak
cazi quimica farmaceutica industria e comercio ltda - mesilato de di-hidroergotamina, dipirona, cafeÍna - analgesicos contra enxaqueca
vacina febre amarela (atenuada)
fundaÇÃo oswaldo cruz - vírus 17d da febre amarela - vacinas
migraliv
ems sigma pharma ltda - analgesicos contra enxaqueca
migraliv
ems s/a - mesilato de di-hidroergotamina, cafeÍna, dipirona monoidratada - analgesicos contra enxaqueca
carvykti®
janssen-cilag farmacÊutica ltda - ciltacabtageno autoleucel - outros antineoplasicos
columvi
roche registration gmbh - glofitamab - lymphoma, large b-cell, diffuse - agentes antineoplásicos - columvi as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl), after two or more lines of systemic therapy.
talvey
janssen-cilag international n.v. - talquetamab - mieloma múltiplo - agentes antineoplásicos - talvey is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least 3 prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti cd38 antibody and have demonstrated disease progression on the last therapy.
tepkinly
abbvie deutschland gmbh & co. kg - epcoritamab - lymphoma, large b-cell, diffuse - agentes antineoplásicos - tepkinly as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) after two or more lines of systemic therapy.
lunsumio
roche registration gmbh - mosunetuzumab - linfoma, folicular - antineoplastic agents, monoclonal antibodies - lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) who have received at least two prior systemic therapies.